536 related articles for article (PubMed ID: 26632446)
1. In situ vaccination: Cancer immunotherapy both personalized and off-the-shelf.
Hammerich L; Binder A; Brody JD
Mol Oncol; 2015 Dec; 9(10):1966-81. PubMed ID: 26632446
[TBL] [Abstract][Full Text] [Related]
2. Personalized approaches to active immunotherapy in cancer.
Ophir E; Bobisse S; Coukos G; Harari A; Kandalaft LE
Biochim Biophys Acta; 2016 Jan; 1865(1):72-82. PubMed ID: 26241169
[TBL] [Abstract][Full Text] [Related]
3. Engineered Nanoparticles for Cancer Vaccination and Immunotherapy.
Aikins ME; Xu C; Moon JJ
Acc Chem Res; 2020 Oct; 53(10):2094-2105. PubMed ID: 33017150
[TBL] [Abstract][Full Text] [Related]
4. In situ vaccination for the treatment of cancer.
Hammerich L; Bhardwaj N; Kohrt HE; Brody JD
Immunotherapy; 2016; 8(3):315-30. PubMed ID: 26860335
[TBL] [Abstract][Full Text] [Related]
5. Cellular therapy approaches harnessing the power of the immune system for personalized cancer treatment.
Bastien JP; Minguy A; Dave V; Roy DC
Semin Immunol; 2019 Apr; 42():101306. PubMed ID: 31604534
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cells for specific cancer immunotherapy.
Meidenbauer N; Andreesen R; Mackensen A
Biol Chem; 2001 Apr; 382(4):507-20. PubMed ID: 11405216
[TBL] [Abstract][Full Text] [Related]
7. Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics.
Guo ZS; Lu B; Guo Z; Giehl E; Feist M; Dai E; Liu W; Storkus WJ; He Y; Liu Z; Bartlett DL
J Immunother Cancer; 2019 Jan; 7(1):6. PubMed ID: 30626434
[TBL] [Abstract][Full Text] [Related]
8. The ReNAissanCe of mRNA-based cancer therapy.
Van Lint S; Renmans D; Broos K; Dewitte H; Lentacker I; Heirman C; Breckpot K; Thielemans K
Expert Rev Vaccines; 2015 Feb; 14(2):235-51. PubMed ID: 25263094
[TBL] [Abstract][Full Text] [Related]
9. The present status and future prospects of peptide-based cancer vaccines.
Hirayama M; Nishimura Y
Int Immunol; 2016 Jul; 28(7):319-28. PubMed ID: 27235694
[TBL] [Abstract][Full Text] [Related]
10. Intratumoral immunotherapy: using the tumor as the remedy.
Marabelle A; Tselikas L; de Baere T; Houot R
Ann Oncol; 2017 Dec; 28(suppl_12):xii33-xii43. PubMed ID: 29253115
[TBL] [Abstract][Full Text] [Related]
11. In vivo cancer vaccination: Which dendritic cells to target and how?
Chiang CL; Kandalaft LE
Cancer Treat Rev; 2018 Dec; 71():88-101. PubMed ID: 30390423
[TBL] [Abstract][Full Text] [Related]
12. Active Immunotherapy of Cancer.
Chodon T; Koya RC; Odunsi K
Immunol Invest; 2015; 44(8):817-36. PubMed ID: 26575466
[TBL] [Abstract][Full Text] [Related]
13. Next generation approaches for tumor vaccination.
Patel A; Kaufman HL; Disis ML
Chin Clin Oncol; 2017 Apr; 6(2):19. PubMed ID: 28482672
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy for the treatment of breast cancer: checkpoint blockade, cancer vaccines, and future directions in combination immunotherapy.
McArthur HL; Page DB
Clin Adv Hematol Oncol; 2016 Nov; 14(11):922-933. PubMed ID: 27930644
[TBL] [Abstract][Full Text] [Related]
15. In-situ tumor vaccination: Bringing the fight to the tumor.
Pierce RH; Campbell JS; Pai SI; Brody JD; Kohrt HE
Hum Vaccin Immunother; 2015; 11(8):1901-9. PubMed ID: 26055074
[TBL] [Abstract][Full Text] [Related]
16. Nanobiomaterial-based vaccination immunotherapy of cancer.
Chen F; Wang Y; Gao J; Saeed M; Li T; Wang W; Yu H
Biomaterials; 2021 Mar; 270():120709. PubMed ID: 33581608
[TBL] [Abstract][Full Text] [Related]
17. Immunoengineering through cancer vaccines - A personalized and multi-step vaccine approach towards precise cancer immunity.
Lybaert L; Vermaelen K; De Geest BG; Nuhn L
J Control Release; 2018 Nov; 289():125-145. PubMed ID: 30223044
[TBL] [Abstract][Full Text] [Related]
18. Imaging the immune response to monitor tumor immunotherapy.
Wang Q; Ornstein M; Kaufman HL
Expert Rev Vaccines; 2009 Oct; 8(10):1427-37. PubMed ID: 19803763
[TBL] [Abstract][Full Text] [Related]
19. On the road to a tumor cell vaccine: 20 years of cellular immunotherapy.
Yannelli JR; Wroblewski JM
Vaccine; 2004 Nov; 23(1):97-113. PubMed ID: 15519713
[TBL] [Abstract][Full Text] [Related]
20. Enhancing efficacy of anticancer vaccines by targeted delivery to tumor-draining lymph nodes.
Jeanbart L; Ballester M; de Titta A; Corthésy P; Romero P; Hubbell JA; Swartz MA
Cancer Immunol Res; 2014 May; 2(5):436-47. PubMed ID: 24795356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]